CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 54 enrolled
Drug / intervention
SMOFlipiddietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04572373
NCT04572373N/ACompleted

Supplements SMOF in TPN for Liver Transplantation Recipients

Chang Gung Memorial Hospital·observational·Posted Oct 1, 2020·Updated Oct 8, 2020

In Brief

An observational study evaluating SMOFlipid for Liver Transplantation and 2 related conditions. Completed, enrolled 54 participants across 1 site.

Detailed Summary

Liver transplantation (LT) is one of the widely recognised and leading treatments for end-stage liver disease. Nutrition impacts its success. Total parenteral nutrition (TPN) is usually prescribed for patients recommended prolonged fasting after LT. The supplement of SMOFlipid (soybean oil, MCT oil, olive oil, and fish oil) is easily metabolised to produce energy, and it possesses anti-inflammatory effects; however, SMOFlipid emulsion use raises concerns regarding coagulopathy after LT. This study investigated the postoperative correlation between SMOFlipid and coagulation in LT.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesTaiwan
Collaborators--

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedOct 1, 2020
Enrollment StartJan 1, 2012
Primary CompletionJun 30, 2015
TodayJul 2, 2026
Enrollment to primary: 3.5 yearsPosted 5.8 years ago

Interventions

SMOFlipiddietary